News Website

Fortis La Femme Convenes GYNAECON 2026 to Chart the Future of Women's Healthcare - healthcareexecutive.in

Fortis La Femme Convenes GYNAECON 2026 to Chart the Future of Women's Healthcare healthcareexecutive.in

Published: Oct. 5, 2026, 10:08 a.m.

Read Full Article

RNA Chemical Tag Drives Endometrial Cancer Through a DNA Repair Protein, Study Finds - Bioengineer.org

RNA Chemical Tag Drives Endometrial Cancer Through a DNA Repair Protein, Study Finds Bioengineer.org

Published: Oct. 2, 2026, 6:10 p.m.

Read Full Article

RNA Chemical Tag Drives Endometrial Cancer Through a DNA Repair Protein, Study Finds - bioengineer.org

RNA Chemical Tag Drives Endometrial Cancer Through a DNA Repair Protein, Study Finds bioengineer.org

Published: Oct. 2, 2026, 6:10 p.m.

Read Full Article

Contemporary OB/GYN's top expert interviews from September 2026 - Contemporary OB/GYN

Contemporary OB/GYN's top expert interviews from September 2026 Contemporary OB/GYN

Published: Oct. 2, 2026, 5:09 p.m.

Read Full Article

Contemporary OB/GYN's top expert interviews from September 2026 - contemporaryobgyn.net

Contemporary OB/GYN's top expert interviews from September 2026 contemporaryobgyn.net

Published: Oct. 2, 2026, 5:09 p.m.

Read Full Article

A long-term gonadotropin-releasing hormone agonist protocol may be associated with increased positive pregnancy outcomes in women with endometriosis undergoing frozen embryo transfer - 2 Minute Medicine

A long-term gonadotropin-releasing hormone agonist protocol may be associated with increased positive pregnancy outcomes in women with endometriosis undergoing frozen embryo transfer 2 Minute Medicine

Published: Oct. 2, 2026, 5:18 a.m.

Read Full Article

A long-term gonadotropin-releasing hormone agonist protocol may be associated with increased positive pregnancy outcomes in women with endometriosis undergoing frozen embryo transfer - 2minutemedicine.com

A long-term gonadotropin-releasing hormone agonist protocol may be associated with increased positive pregnancy outcomes in women with endometriosis undergoing frozen embryo transfer 2minutemedicine.com

Published: Oct. 2, 2026, 5:18 a.m.

Read Full Article

Cannabis Receptors in the Womb: How the Endocannabinoid System May Drive Endometriosis Pain - Bioengineer.org

Cannabis Receptors in the Womb: How the Endocannabinoid System May Drive Endometriosis Pain Bioengineer.org

Published: Oct. 1, 2026, 3:26 p.m.

Read Full Article

Cannabis Receptors in the Womb: How the Endocannabinoid System May Drive Endometriosis Pain - bioengineer.org

Cannabis Receptors in the Womb: How the Endocannabinoid System May Drive Endometriosis Pain bioengineer.org

Published: Oct. 1, 2026, 3:26 p.m.

Read Full Article

Metabolic Enzyme ME1 Emerges as Key to Unlocking Progestin Therapy in Endometrial Cancer - Bioengineer.org

Metabolic Enzyme ME1 Emerges as Key to Unlocking Progestin Therapy in Endometrial Cancer Bioengineer.org

Published: Sept. 30, 2026, 10:09 p.m.

Read Full Article

Latest Articles

Fortis La Femme Convenes GYNAECON 2026 to Chart the Future of Women's Healthcare - healthcareexecutive.in

RNA Chemical Tag Drives Endometrial Cancer Through a DNA Repair Protein, Study Finds - Bioengineer.org

RNA Chemical Tag Drives Endometrial Cancer Through a DNA Repair Protein, Study Finds - bioengineer.org

Contemporary OB/GYN's top expert interviews from September 2026 - Contemporary OB/GYN

Contemporary OB/GYN's top expert interviews from September 2026 - contemporaryobgyn.net

A long-term gonadotropin-releasing hormone agonist protocol may be associated with increased positive pregnancy outcomes in women with endometriosis undergoing frozen embryo transfer - 2 Minute Medicine

A long-term gonadotropin-releasing hormone agonist protocol may be associated with increased positive pregnancy outcomes in women with endometriosis undergoing frozen embryo transfer - 2minutemedicine.com

Cannabis Receptors in the Womb: How the Endocannabinoid System May Drive Endometriosis Pain - Bioengineer.org

Cannabis Receptors in the Womb: How the Endocannabinoid System May Drive Endometriosis Pain - bioengineer.org

Metabolic Enzyme ME1 Emerges as Key to Unlocking Progestin Therapy in Endometrial Cancer - Bioengineer.org

Subscribe to Our Newsletter